Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 21990393

Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2011 Nov 20
First author
Yamaguchi M

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2012 Mar 20;30(9):1015-6; author reply 1016-7. doi: 10.1200/JCO.2011.40.7098.
    note
    Source null
    related pmid
    22331933
    relationship
    Comment in

Authors and identifiers

  1. name
    Yamaguchi M
    type
    Author
  2. name
    Kwong YL
    type
    Author
  3. name
    Kim WS
    type
    Author
  4. name
    Maeda Y
    type
    Author
  5. name
    Hashimoto C
    type
    Author
  6. name
    Suh C
    type
    Author
  7. name
    Izutsu K
    type
    Author
  8. name
    Ishida F
    type
    Author
  9. name
    Isobe Y
    type
    Author
  10. name
    Sueoka E
    type
    Author
  11. name
    Suzumiya J
    type
    Author
  12. name
    Kodama T
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Yamaguchi M
    type
    Author
  2. name
    Kwong YL
    type
    Author
  3. name
    Kim WS
    type
    Author
  4. name
    Maeda Y
    type
    Author
  5. name
    Hashimoto C
    type
    Author
  6. name
    Suh C
    type
    Author
  7. name
    Izutsu K
    type
    Author
  8. name
    Ishida F
    type
    Author
  9. name
    Isobe Y
    type
    Author
  10. name
    Sueoka E
    type
    Author
  11. name
    Suzumiya J
    type
    Author
  12. name
    Kodama T
    type
    Author
bibliography ids
  1. nci-bib-f4ee197101b94b053c773e5b
book metadata
content sha256
93acc5d7a279c53cb1c758a1e4002048d2690010b3b90cbd56b721de6596a411
document type
citation
dois
  1. 10.1200/JCO.2011.35.6287
electronic publication date
display
2011 Oct 11
precision
day
year
2011
evidence scope
bibliographic_metadata_only
id
pubmed:21990393
immutable id
pubmed:21990393@93acc5d7a279c53cb1c758a1e4002048d2690010b3b90cbd56b721de6596a411
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
33
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
4410-6
volume
29
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2012 Mar 20;30(9):1015-6; author reply 1016-7. doi: 10.1200/JCO.2011.40.7098.
    note
    Source null
    related pmid
    22331933
    relationship
    Comment in
outcomes validated
false
pmid
21990393
provenance
batch id
2529ef2eca926738ab13
provider
NCBI PubMed ESummary
record sha256
89c3b5efba1604d16aba018e42c50cd79472a43d8f3e2ae099ee4340c11a7b6b
response sha256
9204e3dd8d67df5a6773613a8059d8d42d9842ee24eecc9b0f39a62f636c99b6
retrieved at
2026-09-09T23:46:42.856296+00:00
publication date
display
2011 Nov 20
precision
day
year
2011
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/21990393/
title
Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study.

Preserved source evidence · Independent clinical review pending · Not medical advice